Position history for BlackRock, Inc.'s holdings in ACADIA PHARMACEUTICAL
BlackRock, Inc. holds 21.6M shares of ACAD (ACADIA PHARMACEUTICAL), worth $479.7M as of 2026-Q1. The position was increased (+3.8% shares). ACAD represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$479.7M
Current Shares
21.6M
Total Value Change
+$246.1M
Total Shares Change
+8.8M
Other major holders of ACAD: BAKER BROS. ADVISORS LP
Increased |
| 21.6M |
+3.8% |
| $479.7M |
| 0.0% |
| $22.50 |
33 |
| 2025-Q4 | Increased | 20.8M | +2.4% | $554.4M | 0.0% | $26.70 | 32 |
| 2025-Q3 | Decreased | 20.3M | -1.9% | $432.5M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Decreased | 20.7M | -3.3% | $445.5M | 0.0% | $22.12 | 0 |
| 2025-Q1 | Increased | 21.4M | +67.8% | $354.9M | 0.0% | $17.07 | 46 |
| 2024-Q4 | New | 12.7M | - | $233.6M | 0.0% | $16.69 | 42 |